Investors have been impressed at the rapid pace at which the stock market has clawed back its losses from early in 2022. The Nasdaq Composite (NASDAQINDEX: ^IXIC) in particular has rebounded sharply, and so it made sense for the index to take a brief break from its ascent early Wednesday. As of 7:45 a.m. ET, Nasdaq futures were down about a third of a percent.
Yet there's still plenty of excitement among individual Nasdaq stocks. Today, investors focused on the biotech stock arena, where a pair of companies saw their share prices rise sharply. Read on to learn why Adagio Therapeutics (NASDAQ: ADGI) and Vir Biotechnology (NASDAQ: VIR) made their way onto market participants' radar screens early Wednesday.
Image source: Getty Images.
For further details see:
These 2 Nasdaq Biotech Stocks Are Soaring Wednesday Morning